NCT02441543View on ClinicalTrials.gov

Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

May 31, 2018

Conditions
SOLID TUMOR
Trial Locations (1)

20089

Istituto Clinico Humanitas, Rozzano

All Listed Sponsors
lead

Istituto Clinico Humanitas

OTHER

NCT02441543 - Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus | Biotech Hunter | Biotech Hunter